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ABSTRACT
Objectives: To identify the reasons why some people
do not participate in bowel cancer screening so that
steps can be taken to improve informed decision-
making.
Design: Qualitative study, using focus groups with
thematic analysis of data to identify, analyse and report
patterns. Transcripts were repeatedly read and
inductively coded using a phenomenological
perspective, and organised into key themes.
Setting: Belfast and Armagh, two areas of Northern
Ireland with relatively low uptake of bowel cancer
screening.
Participants: Ten women and 18 men in three
single-gender focus groups (two male and one
female), each with 9–10 participants. Study
participants were recruited by convenience sampling
from the general public and were eligible for, but had
not taken part in, the Northern Ireland Bowel Cancer
Screening Programme.
Results: Key themes identified were fear of cancer;
the test procedure; social norms; past experience of
cancer and screening; lack of knowledge or
understanding about bowel cancer screening; and
resulting behaviour towards the test. Fear about
receiving bad news and reluctance to conduct the test
themselves were reactions that participants seemed
willing to overcome after taking part in open
discussion about the test.
Conclusions: We identified barriers to participation in
bowel cancer screening and used these insights to
develop new materials to support delivery of the
programme. Some of the issues raised have been
identified in other UK settings, suggesting that
knowledge about barriers, and strategies to improve
uptake, may be generalisable.
INTRODUCTION
The Northern Ireland Bowel Cancer
Screening Programme (NIBCSP) was
launched in 2010 to reduce mortality from
bowel cancer by detecting early-stage
colorectal cancers to facilitate early treatment.
A guaiac faecal occult blood test kit is posted
to all men and women aged 60–74 years,
completed at home by application of three
stool samples to the card and returned to a
laboratory by post. Detection of blood may
indicate bowel cancer and the person is
referred for examination of the bowel, usually
by colonoscopy. The screening programme is
coordinated and quality-assured by the Public
Health Agency (PHA), which is the public
arms-length body with responsibility for
improving public health and reducing health
inequalities in Northern Ireland.
The NIBCSP has the lowest uptake of
Northern Ireland’s regional population screen-
ing programmes at 53.2%. Participation is
lower among men (51% in fourth quarter of
2012–2013) and in speciﬁc areas (46% in
Belfast Health and Social Care Trust and
47.8% in Southern Health and Social Care
Trust). In contrast, 81% of 65-year-old men
offered abdominal aortic aneurysm screening
participate.1
Barriers to bowel cancer screening uptake
have been studied outside the UK and in the
Strengths and limitations of this study
▪ This qualitative study revealed common and con-
sistent barriers to participating in bowel cancer
screening, including fear, reluctance to take a
stool sample and the perception that taking part
was not the social norm.
▪ The study findings were used in practice to
inform production of an explanatory online video
for the public that addressed common
misconceptions about bowel cancer screening.
▪ Including people who had undertaken screening
would have allowed study of enabling factors.
▪ We had limited information about the sociode-
mographic characteristics of study participants.
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UK during pilot and roll-out phases of the English
national bowel cancer screening programme by qualita-
tive and quantitative methods.2–4 More recently, a large
focus group study of reasons for uptake and non-uptake
of the now-established English programme in South
Yorkshire and London provided valuable insights into
barriers to participation.5 Palmer et al5 reported that
interaction with faeces was regarded as taboo, the non-
healthcare setting was unsettling, and feeling well led to
a perception that the test was of low relevance. Themes
that were common to several reports were fear and
disgust, with some gender differences reported.2 6
An informed decision is “one where a reasoned
choice is made by a reasonable individual using relevant
information about the advantages and disadvantages of
all the possible courses of action, in accord with the indi-
vidual’s beliefs.”7 Promoting informed choice is
regarded as an autonomy-respecting approach to cancer
screening that recognises that there are risks, beneﬁts
and uncertainties related to participating in screening
that individuals may weigh differently depending on
their values and their capacities to beneﬁt from screen-
ing.8 People with lower levels of education may have
greater difﬁculty reaching informed decisions about par-
ticipation in bowel cancer screening.9
The aim of our study was to understand reasons for
non-uptake so that steps can be taken to facilitate
informed decision-making. We used a qualitative
approach to elicit and explore bowel screening-related
beliefs, attitudes and knowledge of individuals who did
not participate in the NIBCSP.
METHOD
The PHA commissioned Perceptive Insight, a market
research company that is accredited under the
Interviewer Quality Control Scheme (http://iqcs.org),
to facilitate the focus groups. Research ethics approval
for this study was not required because no Health and
Social Care (HSC) patient information or HSC premises
were used. A UK National Research Authority decision
tree for this project explaining this decision is shown
(see online supplementary methods 1). Participants
gave informed consent after being informed of the
purpose of the study, that their comments would be
conﬁdential and that no identifying information would
be published. No identifying information was passed
from Perceptive Insight to the PHA. The study is
reported with reference to the Consolidated Criteria for
Reporting Qualitative Research (COREQ) guideline to
improve the quality and transparency of reporting of
qualitative studies.10
Recruitment
Purposive recruitment was undertaken by networking,
snowballing and on-street recruitment using an eligibility
questionnaire. Recruitment was in Belfast and Armagh,
representing Belfast and Southern Health and Social
Care Trusts, respectively because these areas have lowest
uptake. Inclusion criteria were:
▸ Age 60–71 (The NIBCSP target age group at the time
of the study).
▸ Had not had bowel disease or surgery that would
make them ineligible for the NIBCSP.
▸ Had not had colonoscopy in previous year and not
on an alternative surveillance programme.
▸ Had not participated in the NIBCSP.
▸ Had not attended a focus group in the past 2 years.
▸ Had not been recently bereaved due to cancer.
Focus groups
Three groups were convened in March 2014: two with
male participants and one with female participants,
because uptake is lower among men (table 1). All parti-
cipants were white, spoke English and were from
Northern Ireland. All had received but not completed a
bowel cancer screening kit except for one focus group
participant who had recently entered the eligible age
range and had not yet received a test kit. Each focus
group was facilitated by one of a team of three female
researchers with extensive experience of conducting
focus groups. Researchers had no contact with partici-
pants prior to the focus groups. Focus groups were held
in hotel conference rooms, lasted 90 min and had 9–10
participants. A topic guide shaped discussions (see
online supplementary methods 2).
Analysis
Audio recordings of the sessions were made, reviewed
and transcribed verbatim by Perceptive Insight.
Transcripts were not shown to participants. Informal
results were reported to PHA by Perceptive Insight.
Thematic analysis using a six-step process12 was under-
taken independently by two authors (DTB and CT).
This is a method for identifying, analysing and reporting
patterns within qualitative data. Themes were derived
inductively from the data with no pre-existing coding
frame from a phenomenological perspective whereby
data were analysed from the perspective of the individ-
ual.13 Codes were collated into potential themes, which
were reviewed and reﬁned to ensure consistency with
the data. Discussions were held to compare and
combine analyses, with a high level of agreement. NVivo
qualitative data analysis software (QSR International Pty
Ltd. V.10, 2012), was used to facilitate data analysis.
Table 1 Characteristics of focus groups
Focus
Group Gender Location
Participants
(n)
Social
grade
range*
1 Male Belfast 9 B–E
2 Male Armagh 9 C1–E
3 Female Belfast 10 B–E
*Social Grade based on National Readership Survey definitions.11
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RESULTS
Six key themes were developed from analysis of data.
Theme 1: Fear of cancer
Fear was one of the major sentiments expressed.
Participants described anxiety, shock and fear provoked
by different aspects of screening. Receipt of the test kit
for the ﬁrst time commonly provoked shock, particularly
among females.
It was a shock, I wasn’t expecting it and you get it as soon
as you’re sixty. Like now I’m sixty they expect me to get
everything. [Female, FG3]
This response appeared related to the idea of sud-
denly being considered ‘old’.
To be honest I was angry, it was telling me I was old.
[Female, FG3]
All of a sudden just because of your age you get this
thing ‘you may have cancer’. [Male, FG2]
However, several people acknowledged that they were
reaching the age that they could be affected.
You’re coming up to the age and you’re afraid. [Female,
FG3]
Some participants thought that waiting on results
would be an anxious time, and many people described
fear about receiving bad news.
It’s kind of scary and it’s all leading up to the result.
[Male, FG1]
Some individuals worried about being called in for
investigations, though others did state that a positive
screening test did not mean a cancer diagnosis.
Well you would nearly have a heart attack if you opened
the letter and you need to come back in. [Female, FG3]
It’ll be no different from breast screening, you some-
times get a call back and it’s not a problem. [Female,
FG3]
Fear was mentioned frequently in the male groups,
several of whom commented that men were less likely to
see doctors or take part in screening than women.
However, some statements suggested that the men recog-
nise the importance of screening.
[W]omen are nearly religious about going and getting
checked for cancer [Male, FG1]
It used to be that men wouldn’t have went to the doctor
unless they were really dying… but now with much more
access to media people are clued in and know of the
importance of early intervention and therefore screening
is so important. [Male, FG1]
Many individuals seemed inhibited from acting by
their fear. Avoidance of thinking about cancer, and a
preference for ‘not knowing’ were expressed several
times. However, this was balanced by numerous state-
ments in favour of knowing.
The treatment as well, it might be invasive and your
whole life might change. Hospitalised, chemo. If it
happens, it happens and I’ll deal with it then. Don’t want
to pre-empt it. [Male, FG1]
I would rather have the result than not have it. [Female,
FG3]
While there was much fear expressed about receiving
a diagnosis of cancer, there was none expressed about
the possibility of having a cancer undiagnosed due to
not taking the test. Rather, some of the participants
acknowledged that a rational understanding of the bene-
ﬁts of bowel screening competed with an intuitive reluc-
tance to take part.
You should want to know, but don’t. [Male, FG1]
If it was my son I would be cross at him telling him to do
it and that it’s important, I’d catch his poo for him but I
won’t do it myself. It doesn’t make any sense. [Female,
FG3]
Some people believed that a negative test result would
be reassuring. Many male (but no female) participants
advocated using fear as a motivational tool in an adver-
tising campaign to ‘shock’ individuals, often referring to
tobacco campaigns.
There’s nothing wrong with scare tactics, they use them
for drink-driving and to stop people smoking. [Male,
FG1].
Theme 2: The test procedure
Repugnance at the idea of screening participants having
to handle their own faeces was often expressed. Many
people described reluctance to collect the samples
though this seemed to present a more signiﬁcant barrier
for females.
I didn’t like the idea of it, collecting my bits of poo.
[Female, FG3]
It’s not the kind of thing you want to do. [Male, FG1]
There were mixed views about how difﬁcult the test
was to use, though no participants said that they had
attempted to complete it. One participant advocated
production of a video to explain how to do the test.
I read the thing, if it had have been a relatively straight
forward [process] I would have done it the one time but
it just looked so complicated. [Male, FG2]
It looks more complicated than it is. [Male, FG1]
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One issue with the test that emerged repeatedly was
taking samples three times. It seemed that many people
might be able to bring themselves to do the test once,
but not three times. Others were concerned about
leaving a partially completed test kit sitting for several
days or having to carry it around with them while away
from home.
You have to do it over a number of days then you have to
have that sitting about somewhere. [Female, FG3]
Sometimes you don’t always be at home, you’re maybe at
work and are you going to have to carry it about all day
with you? [Female, FG3]
Suggestions for making the test more acceptable
involved limiting the need for interacting with faeces:
using an alternative test; using a test that required only
one sample; doing the test in a mobile screening van or
doctors’ surgery; or being investigated by a healthcare
professional.
Why not use a blood sample instead of that. You use a
blood sample for everything else. [Male, FG2]
[If my] doctor told me ‘My colleague is going to
examine you for bowel or prostate cancer’ I would tell
them to work away [go ahead]. [Male, FG2]
I think it is like as this man says degrading, you would
prefer maybe a doctor or nurse than having to do it your-
self. [Male, FG2]
Some people thought that the obligation inherent in
having an appointment with a healthcare professional
would make them more likely to attend.
I don’t look at it the same as a smear test or breast
screening, you’re just used to going for those and you get
your letter regularly and just go for the appointment. You
feel you have to go for the appointment. [Female, FG3]
Many people suggested that if the test involved inter-
action with, or endorsement by, their general practi-
tioner (GP) they would be more likely to participate.
I have mine in the bedroom, because if my GP says do it
then I will do it. [Male, FG2].
Theme 3: Social norms
Several participants said that they found the idea of the
bowel cancer test embarrassing.
Well it is a bit of a taboo subject, your bowel movements.
[Male, FG2]
It’s more embarrassing than a smear or a mammogram.
[Female, FG3]
Some had spoken to others who had taken the test
and felt encouraged to participate.
My friend did it and got back the all clear so she’s put
me in the mind to do it, but her husband won’t do it
either, and she says to me you need to do it but I’d
already threw it in the bin. I will reorder it. [Female,
FG3]
Males suggested that information campaigns should
include a celebrity endorsement by someone who had
been affected by bowel cancer.
I think if you got more personalities to come forward
then they desensitise it or there’s a stigma to it [Male,
FG2]
In all groups, most participants said that they would
take the test after they had discussed their concerns.
I think that we’re able to sit here and discuss is an
encouragement, through the post I think it’s easy to put
aside [Male, FG1]
I will deﬁnitely do it. Everyone sitting talking about, and
we all have the same fears and the same reasons of not
doing it. [Female, FG3].
Theme 4: Past experience of cancer and screening
Most participants knew people who had cancer. Their
anecdotes often focused on the side effects and futility
of treatment.
A lot of the time it’s too late anyway, I’ve seen what
chemo does to someone and that person was going to
get 5 years at the most. [Female, FG3]
The principle that early treatment was more successful
was understood by many people.
[I]f you get it at an early stage you’re more likely to
recover. [Male, FG1]
Other screening tests seemed more acceptable to the
participants. Some men had already undergone screen-
ing for abdominal aortic aneurysm. All females had
undergone screening for breast cancer and some also
for cervical cancer.
Theme 5: Lack of knowledge or understanding about
bowel cancer screening
Almost all participants were surprised when the test kit
arrived and most did not know who had sent it, but a
minority knew people who had taken the test already.
When I got that I didn’t have a clue where it even came
from. [Female, FG3]
Many found the test kit difﬁcult to distinguish from
junk mail and private advertising.
I have been getting several other private companies for
screening under the pretence of trying to look ofﬁcial
when it is really a scam. [Male, FG2]
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They sent me the stuff out and all about the bowel test
but I didn’t do it, it’s like that hidden hearing thing you
think you’re going to end up paying for it. [Female,
FG3]
Many people believed samples had to be taken on
consecutive days (they have up to 10 days to collect
three samples). Several people said that they did not
complete the test because they felt well.
I read the symptoms and just thought I don’t have any of
them. [Male, FG1]
Many participants were surprised at how common
bowel cancer is, and several suggested that this informa-
tion should be used to increase participation in the
programme.
Theme 6: Resulting behaviour towards the test
Participants described a clear pattern of behaviour: The
test kits were set aside for a period of time, possibly with
an intention to complete it at a later stage, and either
kept indeﬁnitely or eventually put in the bin.
I put it somewhere and thought I’ll deal with that
another time. [Female, FG3]
Opened it up had a look at it and just put it in the
corner and thought I’ll do it in a while. [Male, FG1].
DISCUSSION
We have described the fears and beliefs of people who
do not undergo bowel cancer screening in Northern
Ireland. The ﬁndings overlap with some previous
reports, suggesting that some reactions to the screening
programme by its target group are common across the
UK, and perhaps more widely.2 5 6
Many of the themes identiﬁed coincide with common
social-cognitive models of health behaviour decision-
making including social norms, attitudes and beliefs.
Emotions play a critical role in health behaviours and
are often neglected in formal models to understand or
predict health behaviours.14 15 Fear was prominent in
discussion, especially among men. Bowel cancer screen-
ing is the only population cancer screening programme
offered to men in Northern Ireland. An intervention
that engages with the emotions of the screening-eligible
population by using anticipated regret has been trialled
in Scotland to increase uptake in bowel screening in
Scotland.16 The use of anticipated regret has been
shown to increase organ donor registration.17 The per-
ception that treatment (particularly chemotherapy) was
futile was common in our study and in Palmer et al.5
Over-diagnosis and false-positive diagnosis were not
mentioned by participants. In a survey of people invited
to ﬂexible sigmoidoscopy screening, fearing cancer
increased people’s intention to undergo screening,
but not uptake, while ﬁnding thoughts of cancer
uncomfortable predicted lower uptake.18 The behaviour
of ‘delaying uptake, leading to non-uptake’,5 or
‘avoidant procrastination’6 was common in our study.
The proposal by male participants of a ‘shocking’ infor-
mation campaign could have unintended conse-
quences.18 Women did not advocate using fear, but
discussed the need for bowel cancer incidence and
survival rates to be included in information campaigns.
A variety of approaches may be necessary to allow for vari-
ation in individuals’ health information processing style.19
Repugnance towards the test procedure might be over-
come for some people in future by the use of a faecal
immunochemical test (FIT), which requires only one
sample.20 21 A study of FIT testing in Scotland showed
that using FIT resulted in greater uptake, particularly in
deprived areas.22
In our study and in Palmer et al,5 the idea of the test
being ‘degrading’ was expressed in identical terms, and
yet a very encouraging aspect of the focus groups was
that after discussion many of the participants said that
they would now undergo the screening. This supports
the existence of a ‘tipping point’, described by Palmer
et al5 among people who took the test after discussion,
leading them to recommend normalisation of open dis-
cussion. Endorsement of the programme by GPs was
recommended by Palmer et al5 and our ﬁndings also
support this.23 A randomised controlled trial suggested
that an electronically signed GP endorsement letter
boosted participation by 11%.23 The Northern Irish par-
ticipants were particularly supportive of endorsement by
public ﬁgures, such as sportspeople.
Misconceptions could affect uptake: some people
believed that because they did not have symptoms, they
did not need to take the test. It was commonly believed
that the test should be conducted on three consecutive
days. Confusion with junk mail and private ‘screening’
tests appears unique to our study, perhaps due to lower
recognition of Health and Social Care Northern Ireland
branding. Some focus group participants proposed an
online explanatory video, and we have now produced
one to provide information and address misconceptions
that were apparent in this study (available online at
http://www.cancerscreening.hscni.net/2188.htm), and
the ﬁndings of this study will inform future communica-
tions with the public about the NIBCSP. Advance notiﬁ-
cation letters that alert individuals to an upcoming
invitation to screening have been shown to be effective24
and cost-effective25 elsewhere, and we have now started a
pilot of this practice in the NIBCSP.
Our study was limited by its small size and limited
sociodemographic information about participants,
including a lack of information about educational attain-
ment. We excluded people who had taken part in the
programme, so our report cannot shed light on the
factors that motivated them to take the test. The socio-
economic status of participants was similar in all groups,
preventing us from drawing conclusions about differing
levels of educational attainment and other social factors
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on motivations. We were unable to explore the effects of
other illnesses or symptoms on knowledge, attitudes and
beliefs about bowel cancer screening.
We are currently conducting studies of non-
participation in Breast and Cervical Cancer Screening
Programmes and have included groups of screening
attenders in order to explore enabling factors in add-
ition to barriers.
Our study is one of two conducted in the UK since
the national bowel cancer screening programmes have
been implemented fully as part of routine healthcare. It
demonstrates that some barriers to participation, such as
fear and repugnance are persistent over time. This infor-
mation will be valuable in informing policy and public
engagement as the UK cancer screening programmes
continue to evolve. The study provides speciﬁc insights
into reasons for non-uptake of the NIBCSP and these
ﬁndings will be used by the PHA to reduce barriers to
uptake and promote informed decision-making.
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